We’re excited to share an important milestone at PurpleLab: we’ve officially submitted our first-ever response to a federal Request for Comment (RFC), and it’s now live on regulations.gov. Ann Phillips, our Senior Director of Regulatory and Standards, pulled together an impressive response to the FDA’s RFC focused on the use of HL7 FHIR (Fast Healthcare…

PurpleLab®, a leading health tech company specializing in real-world data and medical claims insights, and Payerset, the industry leader in enterprise price transparency data, announced today a strategic partnership to launch a trusted price intelligence solution suite, setting a new standard in healthcare intelligence.  This collaboration empowers healthcare organizations with unparalleled accuracy and actionable insights,…

PurpleLab® provides a real-world data [lab], accelerating the discovery and adoption of healthcare innovations. View where PurpleLab insights have been leveraged.  DeepIntent 5 Questions with PurpleLab: Powering Smarter Healthcare Marketing Read Now 10/09/2025 MM+M PurpleLab builds out healthcare adtech stack amid privacy pressures Read Now 09/11/2025 AdExchanger Pharma advertising was late to digital. Now it’s…

PurpleLab® took part in HLTH 24’s Payer Insights Session on October 20th, 2024. Led by Med City New’s Arundhati Pramar, we were joined on stage by Humana’s Pankhuri Sharma and Managed Care Resource Alliance’s Darren E. Wethers for an insightful discussion on how payers can leverage claims data insights to link reimbursements and preventive care. We invite…

PurpleLab®, a leading healthcare analytics company with one of the largest medical and pharmaceutical claims databases in the US, is pleased to announce its membership in the Network Advertising Initiative (NAI), the leading self-regulatory organization dedicated to responsible data collection and use in digital advertising. In joining the NAI, PurpleLab strengthens its commitment to maintaining…

Study is to assess the SARS-CoV-2 antibody levels over time (2021-2022), measured with the Elecsys Anti-SARS-COV-2 S assay, in the real-world setting, and assess the association between them and subsequent COVID-19 outcomes. Jin, Yue; Yang, Fei; Rank, Christopher; Letovsky, Stanley; Ramge, Peter and Jochum, Simon presented a poster during ISPE 2024. The objective of this…

The company announced the introduction of Alerts to empower stakeholders in the healthcare industry with the most updated and easy-to-understand insights. Wayne, Pennsylvania. Monday, June 3, 2024 – PurpleLab®, a healthcare analytics company that holds one of the largest medical and pharmaceutical claims databases in the US, announced the launch of Alerts today, adding a…

Higher SARS-COV-2 spike antibody levels are associated with reduced risk of subsequent symptomatic and severe COVID-19. Jin, Yue; Yang, Fei; Rank, Christopher; Letovsky, Stanley; Ramge, Peter and Jochum, Simon from Roche Information Solutions, Roche Diagnostics GmbH, Roche Diagnostics Solutions, and Roche Diagnostics International presented a poster during ISPOR 2024. The objective was to assess the…

The company announced the introduction of CLEAR Claims , a solution to help generate faster insights from claims data, helping users answer business questions to drive improved patient outcomes. Wayne, Pennsylvania. Tuesday, August 29, 2023 — PurpleLab™, a healthcare analytics company that holds one of the largest claims databases in the US, announced today the launch of…